Search Results
(
)
Filter by
Filter by health areas, people and populations, or solutions
Filter by EGPAF’s stories, research, resources or news
Issue Briefs
Common Ground for Global Health Policy Brief: Pediatric HIV
Published June 28, 2026
Overview Children* are disproportionately affected by the HIV epidemic yet are consistently deprioritized and underserved compared to other affected populations. UNAIDS’ global treatment targets call for 95% of people living with HIV to know their status; 95% of people who know their status to be on treatment; and 95% of…
Topics:
Advocacy,
Pediatric HIV
Countries:
Global
Journal Articles
Unfinished Business in Elimination of Vertical HIV Transmission and Ensuring HIV-Free Survival
Published June 21, 2026
Journal of the International AIDS Society: Volume 29, Issue S1 How do we finally end pediatric HIV? A new supplement from the Journal of the International AIDS Society unpacks this vital question. Co-edited by EGPAF’s Lynne Mofenson, with a commentary from Team EGPAF, the supplement describes the innovations that can finally…
Topics:
HIV,
Prevention of Mother-to-Child Transmission (PMTCT)
Countries:
Global
Journal Articles
HPV Vaccination Uptake and Acceptability of HPV/HIV Integrated Services Models for Adolescent Girls in Mozambique and Zimbabwe
Published June 2, 2026
This study found that integrating HPV vaccination into HIV prevention and treatment services in Mozambique and Zimbabwe significantly increased vaccine uptake among girls at heightened risk of HPV and cervical cancer, while achieving high caregiver acceptance and satisfaction with the integrated care model.
Topics:
Adolescents,
HIV
Countries:
Mozambique,
Zimbabwe
Journal Articles
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi
Published May 27, 2026
Abstract Background Cryptococcal meningitis (CM) causes 13%–20% of deaths among people living with HIV (PLHIV) globally. We examined the cost-effectiveness of improving access to CM diagnostics and treatment among PLHIV initiating HIV care with a positive serum cryptococcal antigen (CrAg) test in Malawi. Methods We used the CEPAC-I model to…
Topics:
HIV
Countries:
Malawi
Journal Articles
Retention in HIV care before and after implementation of a case management program in Malawi
Published April 8, 2026
Authored by EGPAF-Malawi:Lucky Makonokaya, Shalom Dunga, Louiser Kalitera, Rachel Chamanga, Lazarous Msuku, Cathy Golowa, Zuze Joaki, Ackim Sankhani, Geoffrey Singini, Samantha Makoko, Lilian Jiah, Rhoderick Machekano, Godfrey Woelk & Thulani Maphosa Abstract Background Retaining persons living with HIV (PLHIV) on antiretroviral therapy (ART) and preventing loss-to-follow-up (LTFU) is an ongoing challenge. In Malawi, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) implemented a facility-based…
Topics:
HIV
Countries:
Malawi
Fact Sheets
Issue Briefs
Accelerating Progress to Ending Pediatric HIV
Published March 30, 2026
We are at a critical inflection point for children affected by HIV. In 2024 alone, 120,000 children were newly infected, and, without timely treatment, half of HIV positive infants will not reach their second birthday. Children remain left behind—a child with HIV is 6 times more likely to die than…
Topics:
HIV,
Pediatric HIV
Countries:
Global
Resource
Protecting Lives, Sustaining Progress
Published March 15, 2026
The following landscape analysis of maternal and child health, HIV prevention, diagnosis, and treatment, and the historic strength of U.S. leadership in global aid provides an overview of these key areas of global health and recommendations for U.S. Congressional engagement and prioritization.
Topics:
Advocacy,
Children,
Global Health Security,
Health System Strengthening,
HIV,
Maternal and Child Health,
Mothers and Infants,
Women
Countries:
Global,
United States
Journal Articles
HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique
Published January 8, 2025
Real-world data on HIV drug resistance (HIVDR) after transitioning to tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) are limited. We assessed HIVDR rates and patterns in clients with virological failure (VF) after switching from an NNRTI-based regimen to TLD. A cross-sectional study was conducted in Gaza, Mozambique (August 2021–February 2022), including adults on…
Topics:
HIV
Countries:
Mozambique